Spineway : Report on the October 3, 2019 General Shareholders’ Meeting
Report on the October 3, 2019 General Shareholders’ Meeting
The Spineway Ordinary and Extraordinary Shareholders' Meeting met, on second notice after adjournment, on October 3, 2019 at 11:00 am at the company's registered office.
The number of shares held by the shareholders present or represented was 106,268,324 shares, representing 107,637,749 votes, which meant a turnout of 23.40%. All the resolutions presented were adopted with the exception of the 5th resolution, rejected on the proposal of the Board of Directors.
The approval of these resolutions will allow Spineway to continue its development and acquisitions program.
Next communication: 2019 half-year results – 29 October 2019
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 - ALSPW
Available Tuesday through Thursday
(10 a.m. – 12 p.m.)
+33 (0)811 045 555
Finance et Communication
Upcoming Life Sciences Events
- October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction